What is NDC 68788-7844?

68788-7844 is the product NDC for Cefdinir, Cefdinir 250 mg/5mL powder, for suspension, listed with the FDA by Preferred Pharmaceuticals Inc..

Preferred Pharmaceuticals Inc., NDC labeler code 68788. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cefdinir?

80 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cefdinir NDC 68788-7844 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68788-7844Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68788-7844Add the package segment from the table below.

Product information

Brand name (proprietary): Cefdinir
Generic name (nonproprietary): cefdinir
Active ingredients: Cefdinir — 250 mg/5mL
Dosage form: Powder, For suspension
Route: Oral
Labeler: Preferred Pharmaceuticals Inc.NDC labeler code 68788
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065473
Marketing start: Jan 20, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 68788-7844_4a9cc651-518c-411a-956e-77213d2d1336SPL ID 4a9cc651-518c-411a-956e-77213d2d1336SPL set ID 5b6c1b5d-a1d5-4e08-9077-2af3f38fea4eRxCUI 476576UNII CI0FAO63WC
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match: No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

Product label

Current FDA label (SPL), effective Mar 24, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefdinir and other antibacterial drugs, cefdinir should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Cefdinir for oral suspension is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68788-7844

What is NDC 68788-7844?: 68788-7844 is the product NDC for Cefdinir, Cefdinir 250 mg/5mL powder, for suspension, listed with the FDA by Preferred Pharmaceuticals Inc..
What drug is associated with this NDC?: Cefdinir.
What is the active ingredient?: Cefdinir.
Who is the labeler?: Preferred Pharmaceuticals Inc., NDC labeler code 68788. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cefdinir?: 80 other product NDCs are listed under this name. See all Cefdinir NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Cefdinir NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Cefdinir	Cefdinir 250 mg/5mL	Powder, For suspensionOral	Preferred Pharmaceuticals Inc.	68788-4106	68788-4106-01
Cefdinir	Cefdinir 300 mg/1	CapsuleOral	Major Pharmaceuticals	0904-7563	00904-7563-04
Cefdinir	Cefdinir 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4169	70518-4169-0070518-4169-0170518-4169-02+1 more
Cefdinir	Cefdinir 300 mg/1	CapsuleOral	Northwind Health Company, LLC	82868-059	82868-0059-20
Cefdinir	Cefdinir 300 mg/1	CapsuleOral	AvKARE	42291-043	42291-0043-60
Cefdinir	Cefdinir monohydrate 250 mg/5mL	Powder, For suspensionOral	Preferred Pharmaceuticals Inc.	68788-8655	68788-8655-01
Cefdinir	Cefdinir 300 mg/1	CapsuleOral	American Health Packaging	60687-699	60687-0699-21
Cefdinir	Cefdinir 300 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-8404	68788-8404-02
Cefdinir	Cefdinir 300 mg/1	CapsuleOral	Direct_Rx	72189-423	72189-0423-1472189-0423-20
Cefdinir	Cefdinir 300 mg/1	CapsuleOral	Preferred Pharmaceuticals, Inc.	68788-8323	68788-8323-02

All 81 Cefdinir NDCs

Other NDCs under ANDA 065473

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065473
Product	Strength	Form · route	Labeler	Product NDC
Cefdinir	Cefdinir 250 mg/5mL	Powder, For suspensionOral	A-S Medication Solutions	50090-2735
Cefdinir	Cefdinir 125 mg/5mL	Powder, For suspensionOral	A-S Medication Solutions	50090-6417
Cefdinir	Cefdinir 125 mg/5mL	Powder, For suspensionOral	Proficient Rx LP	63187-835
Cefdinir	Cefdinir 125 mg/5mL	Powder, For suspensionOral	Aurobindo Pharma Limited	65862-218
Cefdinir	Cefdinir 250 mg/5mL	Powder, For suspensionOral	Aurobindo Pharma Limited	65862-219
Cefdinir	Cefdinir 125 mg/5mL	Powder, For suspensionOral	NuCare Pharmaceuticals,Inc.	68071-4970
Cefdinir	Cefdinir 250 mg/5mL	Powder, For suspensionOral	NuCare Pharmaceuticals,Inc.	68071-5106
Cefdinir	Cefdinir 125 mg/5mL	Powder, For suspensionOral	NuCare Pharmaceuticals, Inc.	68071-5318
Cefdinir	Cefdinir 250 mg/5mL	Powder, For suspensionOral	Proficient Rx LP	71205-405
Cefdinir	Cefdinir 125 mg/5mL	Powder, For suspensionOral	DIRECT RX	72189-185
Cefdinir	Cefdinir 250 mg/5mL	Powder, For suspensionOral	DIRECT RX	72189-186